Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
266M
-
Number of holders
-
158
-
Total 13F shares, excl. options
-
158M
-
Shares change
-
+3.12M
-
Total reported value, excl. options
-
$257M
-
Value change
-
-$1.26M
-
Put/Call ratio
-
0.5
-
Number of buys
-
86
-
Number of sells
-
-61
-
Price
-
$1.63
Significant Holders of Sana Biotechnology, Inc. - Common Stock, par value $0.0001 per share (SANA) as of Q4 2024
203 filings reported holding SANA - Sana Biotechnology, Inc. - Common Stock, par value $0.0001 per share as of Q4 2024.
Sana Biotechnology, Inc. - Common Stock, par value $0.0001 per share (SANA) has 158 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 158M shares
of 266M outstanding shares and own 59.27% of the company stock.
Largest 10 shareholders include FMR LLC (33.5M shares), Flagship Pioneering Inc. (25M shares), BlackRock, Inc. (11.9M shares), VANGUARD GROUP INC (10.7M shares), BAILLIE GIFFORD & CO (10.2M shares), CANADA PENSION PLAN INVESTMENT BOARD (10.2M shares), STATE STREET CORP (6.71M shares), Capital World Investors (5.45M shares), GEODE CAPITAL MANAGEMENT, LLC (3.19M shares), and PRICE T ROWE ASSOCIATES INC /MD/ (3.11M shares).
This table shows the top 158 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.